METHOD OF SYNTHESIS OF 1-[[[5-(4-CHLOROPHENYL)-2-FURANYL]METHYLENE]AMINO]- 3-[4-(4-METHYL-1-PIPERAZINYL)BUTYL]-2,4-IMIDAZOLIDINEDIONE DIHYDROCHLORIDE Russian patent published in 2002 - IPC

Abstract RU 2194706 C2

FIELD: organic chemistry, chemical technology, medicine, pharmacy. SUBSTANCE: invention relates to method of synthesis of 1-[[[5-(4- chlorophenyl)-2-furanyl] methylene] -amino] -3-[4-(4-methyl-1-piperazinyl)butyl] -2,4-imidazolidinedione dihydrochloride used as antifibrillary and anti-arrhythmic agent of the general formula: that involves stages: a) interaction of 1-[[[5-(4-chlorophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidinedione of the formula: with reagent with carbon chain taken among 1-bromo-4-chlorobutane, 1,4-dichlorobutane, 1,4-dibromobutane and their mixtures in the presence of weak base taken among group comprising potassium carbonate, sodium carbonate, potassium hydrocarbonate, sodium hydrocarbonate and polar aprotonic solvent to form 3-N- -alkylated 2,4-imidazolidinedione; and b) interaction of indicated crude 3-N-alkylated 2,4- imidazolidinedione with 4-methylpiperazine to form 1-[[[5-94-chlorophenyl)-2-furanyl] methylene] amino]-3- ]4-(4-methyl-1-piperazinyl)butyl]-2,4-imidazolidinedione. EFFECT: improved method of synthesis, increased yield, enhanced purity of end product. 15 cl, 4 ex

Similar patents RU2194706C2

Title Year Author Number
METHOD OF SYNTHESIS OF 1,3-DISUBSTITUTED 4-OXO-CYCLIC UREAS 1999
  • Mehtson Patritsija Ehnn
  • Godlevski Majkl Selden
RU2194705C2
UREA 4-OXOCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT 1992
  • Stehnford Sal'Vatore Pelozi, Ml.
  • Chia-Nien Ju
  • Mark Artur Kalkagno
RU2130935C1
UREA OXOCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, TREATMENT METHOD 1992
  • Pelozi Sal'Vatore Stehnford Ml.
  • Ju Chia-Nien
  • Kalkagno Mark Artur
RU2221788C2
CYCLIC UREA COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT 1992
  • Stehnford Sal'Vatore Pelozi
  • Chia-Nien Ju
RU2142461C1
COMPOUNDS OF CYCLIC URETHAN OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF HUMAN AND OTHER MAMMALIAN TREATMENT SUFFERING WITH CARDIAC ARRHYTHMIA AND/OR ATRIAL FIBRILLATION, A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PATIENTS WITH ARRHYTHMIA AND FIBRILLATION 1992
  • Stehnford Sal'Vatore Pelozi
  • Chia-Nien Ju
RU2125568C1
DERIVATIVES OF 5-HYDRAZINOQUINOLONE, COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF INFECTION DISEASE, METHOD OF TREATMENT AND PROPHYLAXIS 1993
  • Demut Tomas Prosser
  • Uajt Ronal'D Judzhin
RU2126000C1
DERIVATIVES OF 6-(2-IMIDAZOLINYLAMINO)-QUINOLINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO α-2-ADRENORECEPTORS 1994
  • Tomas Li Kapps
  • Piter Dzhulian Morer
RU2143429C1
METHOD FOR PREPARING INTERMEDIATE SUBSTANCES FOR QUINOLONE ANTIBIOTICS 2003
  • Rehndehll Dzhared Linn
RU2289576C2
DERIVATIVES OF QUINOLONE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1998
  • Ledussal' Benua
  • Almstid Dzi-In Kim
  • Grej Dzheffri Lajl
  • Khu Ksiufeng Ehrik
RU2193558C2
DERIVATIVES OF DIHYDROBENZOPYRANE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF TREATMENT 1997
  • Janush Dzhon Majkl
  • Dzhonson Karl Randol'F
  • Senanajake Chandravansha Bandara V.
RU2156762C1

RU 2 194 706 C2

Authors

Mehtson Patritsija Ehnn

Godlevski Majkl Selden

Korroz Daniehl

Guggisberg Iv

Dates

2002-12-20Published

1999-04-27Filed